Meadow Creek Wealth Advisors’s Amgen AMGN Stock Holding History

Meadow Creek Wealth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$609K	Sell	1,682 -440	-21%	-$151K	0.37%	53
2026 Q1	$747K	Buy	2,122 +275	+15%	+$98K	0.48%	45
2025 Q4	$605K	Sell	1,847 -2	-0.1%	-$634	0.39%	51
2025 Q3	$547K	Sell	1,849 -10	-0.5%	-$2.9K	0.36%	55
2025 Q2	$519K	Sell	1,859 -15	-0.8%	-$4.25K	0.35%	60
2025 Q1	$584K	Sell	1,874 -12	-0.6%	-$3.54K	0.44%	53
2024 Q4	$492K	Buy	1,886 +10	+0.5%	+$2.97K	0.35%	58
2024 Q3	$604K	Hold	1,876	–	–	0.48%	47
2024 Q2	$586K	Sell	1,876 -3	-0.2%	-$881	0.55%	43
2024 Q1	$534K	Buy	1,879 +25	+1%	+$7.32K	0.37%	61
2023 Q4	$534K	Buy	+1,854	New	+$505K	0.52%	46
2022 Q3	$423K	Hold	1,877	–	–	0.56%	45
2022 Q2	$457K	Sell	1,877 -74	-4%	-$18.1K	0.56%	43
2022 Q1	$472K	Buy	1,951 +214	+12%	+$49.2K	0.51%	49
2021 Q4	$391K	Buy	+1,737	New	+$367K	0.37%	77
2019 Q4	$210K	Buy	+870	New	+$192K	0.29%	89

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Meadow Creek Wealth Advisors's AMGN Position: Q2 2026 in Review

Meadow Creek Wealth Advisors reduced its Amgen (AMGN) stake by 21% in Q2 2026, selling an estimated $151K and leaving 1,682 shares worth $609K. The position accounts for 0.37% of the portfolio, ranked #53.

Meadow Creek Wealth Advisors first reported a position in AMGN in Q4 2019 and has held it in 16 quarters since. The position peaked at $747K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Meadow Creek Wealth Advisors held 1,682 shares of Amgen worth $609K as of Q2 2026.
Meadow Creek Wealth Advisors sold 440 Amgen shares in Q2 2026, an estimated $151K.
Amgen made up 0.37% of Meadow Creek Wealth Advisors's portfolio in Q2 2026, its #53 holding.
Meadow Creek Wealth Advisors first reported a position in Amgen in Q4 2019 and has held it in 16 quarters since.
Meadow Creek Wealth Advisors's Amgen position peaked at $747K in Q1 2026.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Meadow Creek Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.